Nxtcure Labs

The full-stack AI CRO for drug discovery.

1.2Score#989 of 999 agents#4 of 4 in Clinical trials coordinator

Why it ranks #989

Nxtcure Labs, an AI clinical trials coordinator from YC F26, ranks #989 of 999 AI agents and #4 of 4 in Clinical trials coordinator, with a score of 1.2 of 10. Data as of 3 Oct 2026.

The score adds four parts, each 0 to 10, by weight. Every point comes from public evidence. How scoring works ·

Proof 0 × 30% 0.0
Scale 0 × 30% 0.0
Momentum 1 × 25% 0.3
Autonomy 6 × 15% 0.9
= 1.2

Proof
Do customers use it? 30% of the score
0
No public claims of customers or revenue yet.
Not found: revenue or growth (+4), named customers (+3), a customer result (+2), a customer count (+2), work done at scale (+2)
Scale
Is there a real company behind it? 30% of the score
0
Team size and funding not listed.
Not found: funding round in its news (+3)
Momentum
Is it shipping and growing now? 25% of the score
1
Shows a new batch.
- +1
  New: YC Fall 2026
Not found: launch YC post in the last 6 months (+3), open roles on YC (+2), new traction claim in the last 6 months (+2), funding news in the last year (+2)
Autonomy
How much of the job does it do on its own? 15% of the score
6
Supervised agent: takes actions in other systems; a person approves key steps.
- +6
  Level 2 of 4: Supervised agentTakes actions in other systems; a person approves key steps.
What the model read
- Acts in other systems: 39% likely
- Finishes whole tasks: 23% likely
- Calls itself an agent: 2% likely
- Level 1 from the model's reading of its pages; the evidence review found, with quotes, that its AI acts in the work, so the level is 2
- An AI-native service: it sells the finished work, so it counts as an agent at any level
Level 2: Takes actions in other systems; a person approves key steps.

About Nxtcure Labs

Reinventing medicine from lab to drug discovery. NxtCure CRO- an AI-native, full-stack CRO built to take therapeutics from discovery to market faster. NxtCure Cancer- the all-in-one mobile platform guiding patients through the cancer journey. We’re building the operating system for the future of medicine.